Sorafenib is used for liver cell carcinoma (HCC) and renal cell carcinoma (RCC), among others. The chemotherapeutic agent belongs to the so-called tyrosine kinase inhibitors, which attack chemical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback